Health & Medicine
Cough Syrup Down Syndrome: BTD-001 Used to Improve Memory, Language and Learning
Kathleen Lees
First Posted: Mar 26, 2013 11:08 PM EDT
An ingredient in cough mixture may hold the key to improving language skills for people with Down Syndrome.
According to researchers from Monash University believe BTD-001 -an ingredient in cough syrup that was first discovered in the 1920s-may be able to improve the memory, language and learning of people with the condition.
Associate Professor Bob Davis, who is the head of the centre for Developmental Disability Health at Monash University, said throughout the last century BTD-001 has been prescribed for everything from persistent coughs to Alzheimer's disease, according to Yahoo News.
"In the 1950s and 60s it was used ... as an ingredient for a drug for people with dementia," he said.
"People with dementia seemed to improve their memory and ... cognitive ability, so the ability to think.
"At that stage the medication had been shown to be safe and while there were some small studies indicating that it seemed to work, it didn't have the large drug trials that are required nowadays."
Since then, Prof Davis said it has been established that BTD-001 improves the conductivity of the nerves in the brain, adding that the US research foundation that in comparison to the general population, the nerves in people with Down Syndrome have less conductivity and a diminished ability to store information.
His study is based in Australia and New Zealand and aims at identifying how memory and cognitive ability is affected by the medication.
Catherine McAlpine, head of Down Syndrome Australia, welcomes the research but has some reservations.
"There are very few research projects into helping people with Down Syndrome and the primary area of research is in prenatal testing which has its own ethical boundaries and ethical issues," she said.
"Clearly, if we can do things that help people with Down Syndrome be more independent, then that's a good thing for everyone.
"But it can be a little bit complicated when we are talking about quality of life and increased cognition being one and the same because they're not the same thing."
There are about 6 million people with Down Syndrome worldwide.
See Now:
NASA's Juno Spacecraft's Rendezvous With Jupiter's Mammoth Cyclone
©2024 ScienceWorldReport.com All rights reserved. Do not reproduce without permission. The window to the world of science news.
More on SCIENCEwr
First Posted: Mar 26, 2013 11:08 PM EDT
An ingredient in cough mixture may hold the key to improving language skills for people with Down Syndrome.
According to researchers from Monash University believe BTD-001 -an ingredient in cough syrup that was first discovered in the 1920s-may be able to improve the memory, language and learning of people with the condition.
Associate Professor Bob Davis, who is the head of the centre for Developmental Disability Health at Monash University, said throughout the last century BTD-001 has been prescribed for everything from persistent coughs to Alzheimer's disease, according to Yahoo News.
"In the 1950s and 60s it was used ... as an ingredient for a drug for people with dementia," he said.
"People with dementia seemed to improve their memory and ... cognitive ability, so the ability to think.
"At that stage the medication had been shown to be safe and while there were some small studies indicating that it seemed to work, it didn't have the large drug trials that are required nowadays."
Since then, Prof Davis said it has been established that BTD-001 improves the conductivity of the nerves in the brain, adding that the US research foundation that in comparison to the general population, the nerves in people with Down Syndrome have less conductivity and a diminished ability to store information.
His study is based in Australia and New Zealand and aims at identifying how memory and cognitive ability is affected by the medication.
Catherine McAlpine, head of Down Syndrome Australia, welcomes the research but has some reservations.
"There are very few research projects into helping people with Down Syndrome and the primary area of research is in prenatal testing which has its own ethical boundaries and ethical issues," she said.
"Clearly, if we can do things that help people with Down Syndrome be more independent, then that's a good thing for everyone.
"But it can be a little bit complicated when we are talking about quality of life and increased cognition being one and the same because they're not the same thing."
There are about 6 million people with Down Syndrome worldwide.
See Now: NASA's Juno Spacecraft's Rendezvous With Jupiter's Mammoth Cyclone